Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma

Journal of Clinical Neuroscience

Volumn 19, Issue 7, 2012, Pages 1016-1021

  Syed, Omar N ^a   Mandigo, Christopher E ^a   Killory, Brendan D ^a   Canoll, Peter ^a   Bruce, Jeffrey N ^a  

^a Columbia University ^*  (United States)

Author keywords

Cancer testis antigens; Glioma antigens; Glioma immunology; Melanocyte differentiation antigens; Meningioma antigens

Indexed keywords

CANCER TESTIS ANTIGEN; MELANOCYTE DIFFERENTIATION ANTIGEN; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 3; ONCOPROTEIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; GAMETOGENESIS; GLIA CELL; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; MELANOCYTE; MENINGIOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MELANOMA-SPECIFIC ANTIGENS; MENINGEAL NEOPLASMS; MENINGIOMA; RNA, MESSENGER;

EID: 84862228799     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2011.10.008     Document Type: Article

References (74)

1. I.F. Parney, C. Hao, and K.C. Petruk Glioma immunology and immunotherapy Neurosurgery 46 2000 778 791 [discussion 791-772]
2. T.S. Surawicz, F. Davis, and S. Freels Brain tumor survival: results from the National Cancer Data Base J Neurooncol 40 1998 151 160 (Pubitemid 29010168)
3. R.M. Prins, S.K. Odesa, and L.M. Liau Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model Cancer Res 63 2003 8487 8491 (Pubitemid 37549505)
4. D.D. Chi, R.E. Merchant, and R. Rand Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas Am J Pathol 150 1997 2143 2152 (Pubitemid 27233085)
5. M.E. Dudley, and S.A. Rosenberg Adoptive-cell-transfer therapy for the treatment of patients with cancer Nat Rev Cancer 3 2003 666 675 (Pubitemid 37328821)
6. M.J. Scanlan, A.O. Gure, and A.A. Jungbluth Cancer/testis antigens: an expanding family of targets for cancer immunotherapy Immunol Rev 188 2002 22 32 (Pubitemid 35398862)
7. M.J. Scanlan, A.J. Simpson, and L.J. Old The cancer/testis genes: review, standardization, and commentary Cancer Immun 4 2004 1
8. Y.T. Chen, A.O. Gure, and S. Tsang Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library Proc Natl Acad Sci USA 95 1998 6919 6923 (Pubitemid 28278082)
9. A.K. Struss, B.F. Romeike, and A. Munnia PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme Oncogene 20 2001 4107 4114 (Pubitemid 32762185)
10. R. Schmits, B. Cochlovius, and G. Treitz Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas Int J Cancer 98 2002 73 77 (Pubitemid 34113421)
11. U. Sahin, O. Tureci, and H. Schmitt Human neoplasms elicit multiple specific immune responses in the autologous host Proc Natl Acad Sci USA 92 1995 11810 11813 (Pubitemid 26014201)
12. A.J. Zendman, D.J. Ruiter, and G.N. Van Muijen Cancer/testis-associated genes: identification, expression profile, and putative function J Cell Physiol 194 2003 272 288 (Pubitemid 36176890)
13. L.J. Old Cancer vaccines 2003: opening address Cancer Immun 3 Suppl. 2 2003 1
14. S. Mocellin, C.R. Rossi, and D. Nitti Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines Biochim Biophys Acta 1653 2003 61 71 (Pubitemid 37487648)
15. H.T. Khong, and S.A. Rosenberg Pre-existing immunity to tyrosinase-related protein (TRP)-2, a new TRP-2 isoform, and the NY-ESO-1 melanoma antigen in a patient with a dramatic response to immunotherapy J Immunol 168 2002 951 956 (Pubitemid 34049600)
16. G. Liu, H.T. Khong, and C.J. Wheeler Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma J Immunother 26 2003 301 312 (Pubitemid 36858714)
17. J.S. Yu, G. Liu, and H. Ying Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma Cancer Res 64 2004 4973 4979 (Pubitemid 38924545)
18. G. Liu, H. Ying, and G. Zeng HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells Cancer Res 64 2004 4980 4986 (Pubitemid 38924546)
19. G. Liu, Y. Akasaki, and H.T. Khong Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy Oncogene 24 2005 5226 5234 (Pubitemid 41192439)
20. J. Skog Glioma-specific antigens for immune tumor therapy Expert Rev Vaccines 5 2006 793 802 (Pubitemid 46021057)
21. D.E. Spaner, I. Astsaturov, and T. Vogel Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100 Cancer 106 2006 890 899 (Pubitemid 43238457)
22. N. van Baren, M.C. Bonnet, and B. Dreno Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells J Clin Oncol 23 2005 9008 9021 (Pubitemid 46211485)
23. D.L. Scarcella, C.W. Chow, and M.F. Gonzales Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers Clin Cancer Res 5 1999 335 341 (Pubitemid 29085187)
24. M. Ayyoub, R.N. Taub, and M.L. Keohan The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma Cancer Immun 4 2004 7
25. U. Sahin, M. Koslowski, and O. Tureci Expression of cancer testis genes in human brain tumors Clin Cancer Res 6 2000 3916 3922
26. C. Kasuga, Y. Nakahara, and S. Ueda Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapy. Laboratory investigation J Neurosurg Pediatrics 1 2008 305 313 (Pubitemid 351534716)
27. S.M. Oba-Shinjo, O.L. Caballero, and A.A. Jungbluth Cancer-testis (CT) antigen expression in medulloblastoma Cancer Immun 8 2008 7
28. M.H. Lee, E.I. Son, and E. Kim Expression of cancer-testis genes in brain tumors J Korean Neurosurg Soc 43 2008 190 193
29. D. Rimoldi, P. Romero, and S. Carrel The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas Int J Cancer 54 1993 527 528 (Pubitemid 23169697)
30. J.P. Vonsattel, M.P. Del Amaya, and C.E. Keller Twenty-first century brain banking. Processing brains for research: the Columbia University methods Acta Neuropathol 115 2008 509 532
31. Y.T. Chen, M.J. Scanlan, and U. Sahin A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening Proc Natl Acad Sci USA 94 1997 1914 1918 (Pubitemid 27113936)
32. B. Lethe, S. Lucas, and L. Michaux LAGE-1, a new gene with tumor specificity Int J Cancer 76 1998 903 908 (Pubitemid 28262112)
33. P. van der Bruggen, C. Traversari, and P. Chomez A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma Science 254 1991 1643 1647 (Pubitemid 21917508)
34. B. Gaugler, B. Van den Eynde, and P. van der Bruggen Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes J Exp Med 179 1994 921 930 (Pubitemid 24065650)
35. D. Rimoldi, S. Salvi, and D. Reed CDNA and protein characterization of human MAGE-10 Int J Cancer 82 1999 901 907 (Pubitemid 29384344)
36. O. Tureci, U. Sahin, and I. Schobert The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40 Cancer Res 56 1996 4766 4772 (Pubitemid 26338082)
37. A.O. Gure, E. Stockert, and K.C. Arden CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis Int J Cancer 85 2000 726 732 (Pubitemid 30080489)
38. P. Boel, C. Wildmann, and M.L. Sensi BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes Immunity 2 1995 167 175
39. O. Tureci, U. Sahin, and C. Zwick Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens Proc Natl Acad Sci USA 95 1998 5211 5216 (Pubitemid 28208577)
40. R.F. Wang, S.L. Johnston, and S. Southwood Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33 J Immunol 160 1998 890 897 (Pubitemid 28049332)
41. R.F. Wang, E. Appella, and Y. Kawakami Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes J Exp Med 184 1996 2207 2216 (Pubitemid 27023721)
42. P.G. Coulie, V. Brichard, and A. Van Pel A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas J Exp Med 180 1994 35 42 (Pubitemid 24181053)
43. Y. Kawakami, S. Eliyahu, and C.H. Delgado Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor Proc Natl Acad Sci USA 91 1994 3515 3519 (Pubitemid 24139460)
44. Y. Kawakami, S. Eliyahu, and C.H. Delgado Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection Proc Natl Acad Sci USA 91 1994 6458 6462
45. S. Saikali, T. Avril, and B. Collet Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy J Neurooncol 81 2007 139 148 (Pubitemid 44963972)
46. L. Driggers, J.G. Zhang, and E.W. Newcomb Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper J Neurooncol 97 2010 159 169
47. J.G. Zhang, J. Eguchi, and C.A. Kruse Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics Clin Cancer Res 13 2007 566 575 (Pubitemid 46225363)
48. J.G. Zhang, C.A. Kruse, and L. Driggers Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy J Neurooncol 88 2008 65 76
49. H. Colman, L. Zhang, and E.P. Sulman A multigene predictor of outcome in glioblastoma Neuro Oncol 12 2010 49 57
50. S. Dong, C.L. Nutt, and R.A. Betensky Histology-based expression profiling yields novel prognostic markers in human glioblastoma J Neuropathol Exp Neurol 64 2005 948 955 (Pubitemid 41668924)
51. D. Gabeau-Lacet, D. Engler, and S. Gupta Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome J Neuropathol Exp Neurol 68 2009 1155 1165
52. M. Jansen, S. Yip, and D.N. Louis Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers Lancet Neurol 9 2010 717 726
53. S. Yip, A.J. Iafrate, and D.N. Louis Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers J Neuropathol Exp Neurol 67 2008 1 15
54. L.J. Old Cancer vaccines: an overview Cancer Immun 8 Suppl. 1 2008 1
55. P.G. Coulie, V. Karanikas, and D. Colau A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3 Proc Natl Acad Sci USA 98 2001 10290 10295 (Pubitemid 32803013)
56. M. Marchand, N. van Baren, and P. Weynants Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1 Int J Cancer 80 1999 219 230 (Pubitemid 29001725)
57. E. Jager, S. Gnjatic, and Y. Nagata Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers Proc Natl Acad Sci USA 97 2000 12198 12203
58. M.J. Hickey, C.C. Malone, and K.L. Erickson Cellular and vaccine therapeutic approaches for gliomas J Transl Med 8 2010 100
59. P.R. Walker, T. Calzascia, and P.Y. Dietrich All in the head: obstacles for immune rejection of brain tumours Immunology 107 2002 28 38
60. P.R. Walker, T. Calzascia, and N. de Tribolet T-cell immune responses in the brain and their relevance for cerebral malignancies Brain Res Brain Res Rev 42 2003 97 122 (Pubitemid 36549171)
61. R.M. Prins, and L.M. Liau Immunology and immunotherapy in neurosurgical disease Neurosurgery 53 2003 144 152 [discussion 152-143]
62. M.Y. Yang, P.M. Zetler, and R.M. Prins Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications Expert Rev Neurother 6 2006 1481 1494 (Pubitemid 44690918)
63. M. Hatano, J. Eguchi, and T. Tatsumi EphA2 as a glioma-associated antigen: a novel target for glioma vaccines Neoplasia 7 2005 717 722
64. H. Okada, K.L. Low, and G. Kohanbash Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas J Neurooncol 88 2008 245 250
65. R. Ueda, K.L. Low, and X. Zhu Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma J Transl Med 5 2007 68
66. H. Okada, and I.F. Pollack Cytokine gene therapy for malignant glioma Expert Opin Biol Ther 4 2004 1609 1620 (Pubitemid 39371756)
67. A.P. Liggins, S.H. Lim, and E.J. Soilleux A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies Cancer Immun 10 2010 8
68. E.B. Walker, D. Haley, and W. Miller Gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells Clin Cancer Res 10 2004 668 680 (Pubitemid 38174007)
69. C.L. Slingluff Jr., G.R. Petroni, and W. Olson Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens J Clin Oncol 26 2008 4973 4980
70. E.B. Walker, D. Haley, and U. Petrausch Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization Clin Cancer Res 14 2008 5270 5283
71. J.A. Sosman, C. Carrillo, and W.J. Urba Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma J Clin Oncol 26 2008 2292 2298
72. C. Sioka, and A.P. Kyritsis Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas J Neurooncol 92 2009 1 6
73. M.G. Mathieu, A.J. Linley, and S.P. Reeder HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers Cancer Immun 10 2010 2
74. T. Talebi, and J.S. Weber Peptide vaccine trials for melanoma: preclinical background and clinical results Semin Cancer Biol 13 2003 431 438 (Pubitemid 38156135)